|
|
|
|
|
Mr. Jonathan Fleming, Managing General Partner, joined Oxford Bioscience Partners in 1996 and has been in the investment business for over twenty years, starting and financing growth companies in the United States, Europe, and Israel. For additional information on Mr. Fleming click here |
|
|
Mr. Rick Geoffrion, Vice President of Marketing and Strategic Planning, Invatec, Frauenfeld, Switzerland, possesses over 20 years of management and investment experience in the medical device industry. For additional information on Mr. Geoffrion click here |
|
|
Mr. Avi Molcho, Venture-Partner, joined Forbion Capital Partners in early 2007 mainly on medical technologies opportunities. For additional information on Mr. Molcho click here |
|
|
Ms. Alexia Perouse, Director, Crédit Agricole Private Equity, joined Crédit Agricole Private Equity in 2005 and possesses over 10 years of investment experience in Life Sciences. For additional information on Ms. Perouse click here |
|
|
Mr. Paul Southworth, President and CEO, CircuLite, Inc., joined CircuLite in 2004 with over 30 years experience in the medical device industry. For additional information on Mr. Southworth click here |
|
|
Mr. Martien van Osch, Managing Partner, Forbion Capital Partners (formerly ABN AMRO Capital Life Sciences), joined ABN AMRO in 1996 and has a Masters Degree in Econometrics and Finance from the University of Groningen, Netherlands. For additional information on Mr. van Osch click here |
|
|
Dr. Lee Wrubel, General Partner, Foundation Medical Partners, has over 10 years experience in the field of equity investment and has been associated with a large number of privates companies and now public companies. For additional information on Dr. Wrubel click here |